Buckley Wealth Management’s GSK GSK Stock Holding History

Buckley Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Buy	21,069 +6,489	+45%	+$343K	0.28%	73
2026 Q1	$812K	Buy	+14,580	New	+$790K	0.21%	81
2018 Q4	–	Sell	-4,404	Closed	-$221K	–	145
2018 Q3	$221K	Sell	4,404 -160	-4%	-$8.13K	0.1%	147
2018 Q2	$230K	Hold	4,564	–	–	0.11%	148
2018 Q1	$223K	Sell	4,564 -500	-10%	-$23.3K	0.11%	151
2017 Q4	$225K	Buy	+5,064	New	+$234K	0.11%	153

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Buckley Wealth Management's GSK Position: Q2 2026 in Review

Buckley Wealth Management increased its GSK (GSK) stake by 45% in Q2 2026, buying an estimated $343K and bringing the position to 21,069 shares worth $1.11M. The position accounts for 0.28% of the portfolio, ranked #73.

Buckley Wealth Management first reported a position in GSK in Q4 2017 and has held it in 6 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Buckley Wealth Management held 21,069 shares of GSK worth $1.11M as of Q2 2026.
Buckley Wealth Management bought 6,489 GSK shares in Q2 2026, an estimated $343K.
GSK made up 0.28% of Buckley Wealth Management's portfolio in Q2 2026, its #73 holding.
Buckley Wealth Management first reported a position in GSK in Q4 2017 and has held it in 6 quarters since.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Buckley Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.